TY - JOUR
T1 - Inhibition of CD4 cross-linking - Induced lymphocytes apoptosis by vesnarinone as a novel immunomodulating agent
T2 - Vesnarinone inhibits fas expression and apoptosis by blocking cytokine secretion
AU - Oyaizu, Naoki
AU - Mc Closkey, Thomas W.
AU - Than, Soe
AU - Pahwa, Savita
N1 - Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 1996/3/15
Y1 - 1996/3/15
N2 - Evidence is accumulating that T cells from human immunodeficiency virus type 1 (HIV-1)-infected individuals show accelerated cell death through apoptosis. We have recently demonstrated that the cross-linking of CD4 molecules (CD4XL) results in death of normal peripheral T cells through apoptosis and imbalanced cytokine secretion (ie, induction of tumor necrosis factor-α [TNF-α] and interferon-γ [IFN-γ] in the absence of interleukin-2 [IL-2] or IL-4 secretion). These upregulated cytokines (TNF-a/IFN-γ) largely contributed to upregulation of the apoptosis-inducing cell surface molecule, Fas (APO-1/CD95] and apoptosis induction. The present study investigated the effect of vesnarinone as a novel immunomodulating agent on CD4XL-induced T-cell apoptosis. The addition of vesnarinone to peripheral blood mononuclear cells (PBMC) significantly inhibited CD4XL-induced lymphocyte apoptosis. This apoptosis-inhibitory effect of vesnarinone was associated with the blocking of CD4XL-induced TNF-α and IFN-γ secretion and of Fas antigen upregulation. However, vesnarinone did not block effects of exogenously supplemented TNF-α/IFN-γ on Fas induction. These data suggest that vesnarinone inhibits CD4XL induced TNF-α/IFN-γ secretion, thereby blocking subsequent Fas upregulation and apoptosis induction. Given the potent pathogenic role of imbalanced cytokine secretion observed in HIV-infection, an agent such as vesnarinone may be of therapeutic value in slowing disease progression.
AB - Evidence is accumulating that T cells from human immunodeficiency virus type 1 (HIV-1)-infected individuals show accelerated cell death through apoptosis. We have recently demonstrated that the cross-linking of CD4 molecules (CD4XL) results in death of normal peripheral T cells through apoptosis and imbalanced cytokine secretion (ie, induction of tumor necrosis factor-α [TNF-α] and interferon-γ [IFN-γ] in the absence of interleukin-2 [IL-2] or IL-4 secretion). These upregulated cytokines (TNF-a/IFN-γ) largely contributed to upregulation of the apoptosis-inducing cell surface molecule, Fas (APO-1/CD95] and apoptosis induction. The present study investigated the effect of vesnarinone as a novel immunomodulating agent on CD4XL-induced T-cell apoptosis. The addition of vesnarinone to peripheral blood mononuclear cells (PBMC) significantly inhibited CD4XL-induced lymphocyte apoptosis. This apoptosis-inhibitory effect of vesnarinone was associated with the blocking of CD4XL-induced TNF-α and IFN-γ secretion and of Fas antigen upregulation. However, vesnarinone did not block effects of exogenously supplemented TNF-α/IFN-γ on Fas induction. These data suggest that vesnarinone inhibits CD4XL induced TNF-α/IFN-γ secretion, thereby blocking subsequent Fas upregulation and apoptosis induction. Given the potent pathogenic role of imbalanced cytokine secretion observed in HIV-infection, an agent such as vesnarinone may be of therapeutic value in slowing disease progression.
UR - http://www.scopus.com/inward/record.url?scp=0029932280&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029932280&partnerID=8YFLogxK
U2 - 10.1182/blood.v87.6.2361.bloodjournal8762361
DO - 10.1182/blood.v87.6.2361.bloodjournal8762361
M3 - Article
C2 - 8630399
AN - SCOPUS:0029932280
VL - 87
SP - 2361
EP - 2368
JO - Blood
JF - Blood
SN - 0006-4971
IS - 6
ER -